Stre Homo Liquid
NDC Package 43742-2262-1
Package Information
Stre Homo (dna, enterococcus faecalis, streptococcus agalactiae, streptococcus bovis , streptococcus dysgalactiae, streptococcus mutans, streptococcus oralis, streptococcus pneumoniae, streptococcus uberis, streptococcus viridans) liquids is 1-10 drops under the tongue, 3 times a day or as directed by a health professional. This formulation utilizes a liquid delivery system. Marketed by Deseret Biologicals, Inc., this product is identified by NDC 43742-2262.
Identification & Billing
Clinical Specifications
- ENTEROCOCCUS FAECALIS 15 [hp_X]/mL
- HERRING SPERM DNA 15 [hp_X]/mL
- STREPTOCOCCUS AGALACTIAE 15 [hp_X]/mL
- STREPTOCOCCUS DYSGALACTIAE 15 [hp_X]/mL
- STREPTOCOCCUS EQUINUS 15 [hp_X]/mL
- STREPTOCOCCUS MUTANS 15 [hp_X]/mL
- STREPTOCOCCUS ORALIS 15 [hp_X]/mL
- STREPTOCOCCUS PNEUMONIAE 15 [hp_X]/mL
- STREPTOCOCCUS UBERIS 15 [hp_X]/mL
- STREPTOCOCCUS VIRIDANS GROUP 15 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 43742 - Deseret Biologicals, Inc.
- 43742-2262 - Stre Homo
- 43742-2262-1 - 30 mL in 1 BOTTLE, DROPPER
- 43742-2262 - Stre Homo
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43742-2262-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Stre Homo, a human over the counter drug labeled by Deseret Biologicals, Inc.. This liquid is formulated for oral use and contains enterococcus faecalis; herring sperm dna; streptococcus agalactiae; streptococcus dysgalactiae; streptococcus equinus; streptococcus mutans; streptococcus oralis; streptococcus pneumoniae; streptococcus uberis; streptococcus viridans group as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deseret Biologicals, Inc. on April 09, 2025. The current certification is valid through December 31, 2026.
How is this Deseret Biologicals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43742226201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.